Peripheral Metabolic Effects of Somatostatin

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: Male

Summary

The aim of this study is to investigate peripheral effects of Somatostatin on glucose metabolism and growth hormone (GH) signalling in healthy men. Eight subjects will be enrolled. The hypothesis is that Somatostatin infusion reverses insulin resistance caused by GH.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Aarhus
• Collaborator: The Ministry of Science, Technology and Innovation, Denmark
• Treatments: Somatostatin

Criteria

Inclusion Criteria:

• BMI < 27 kg/m2

• Written informed consent

• Healthy

Exclusion Criteria:

• Any disease

• Any use of medications

• Present or previous malignancy

• Alcohol dependency

• Allergy to trial medication